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Background
In Australia, the DHHS guidelines for treatment of
adults and adolescents have been adopted with an
Australian Commentary.
Purpose of the study
An audit was conducted to determine adherence to
these guidelines.
Methods
Case records were examined of 500 sequential adults
initiating ART in primary care and hospital sites (125
per site) in Sydney and Melbourne from 2004 to 2008
inclusive. Data on ART initiation and regimen pre-
scribed, as well as adherence to all specific guidelines on
patient management and monitoring, were recorded.
Results
Of 500 subjects initiating ART (by 54 physicians with
mean 14 years HIV experience), 95% were male (mean
age 40 years, CD4 count 287 cells/µL, HIV RNA 89,000
copies/mL). ART initiation was mean 3.1 years after diag-
nosis, via clinical trial in 20.4% and as hospital in-patient
in 7.7%. For “When to start”, adherence to Dec 1 2009
guidelines was 91%, 82% for Nov 3 2008 guidelines, and
88% for guidelines current at ART initiation. Preferred or
alternative regimens were prescribed (after exclusion of
patients receiving experimental clinical trial regimens) in
79%, 90%, and 89%, according to 2009, 2008 and guide-
lines current at ART initiation, respectively. Preferred
regimen was prescribed according to guidelines in 50%,
55% and 65%, respectively. Contraindicated ART was
prescribed in 4%. Strong recommendations (level A) in
2008 guidelines were adhered to variably: for hepatitis
serology (74%), oral/dental check (63%), fasting lipids
(52%), fasting glucose (47%), CMV serology (50%), resis-
tance testing (48%), vaccination history 39%, Chlamydia
screening (38%), gonorrhea screening (36%), chest X ray
(35%), pap smear (32%), urinalysis (26%), and TB testing
(9%). Sydney patients were more likely than Melbourne
patients to have co-morbidity history assessed (96% vs
62%, p<0.0001), and to commence ART via a clinical trial
(36% vs 5%, p<0.0001), but less likely to have treatment
adherence ability assessed (62 vs 84%, p<0.0001) with no
significant difference in STI testing. Hospital sites were
more likely than GP sites to perform investigations -
resistance testing (71 vs 46%, p<0.0001), but less likely to
discuss lifestyle health promotion (36% vs 63%, p<0.001).
Conclusions
HIV treatment guidelines in primary care and hospital
sites in Australia have been largely adhered to for when
to start and what to start with, but less closely followed
for co-morbidity related parameters.
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